| Identification | |
| Name: | D-Norvaline,5-phosphono- |
| Synonyms: | (-)-2-Amino-5-phosphonopentanoicacid;(-)-2-Amino-5-phosphonovaleric acid;(R)-2-Amino-5-phosphonopentanoicacid;(R)-AP-5;5-Phosphono-D-norvaline;D-(-)-2-Amino-5-phosphonopentanoicacid;D-2-Amino-5-phosphonopentanoic acid;D-2-Amino-5-phosphonovaleric acid;D-AP-5;D-Aminophosphonovaleric acid; |
| CAS: | 79055-68-8 |
| Molecular Formula: | C5H12NO5P |
| Molecular Weight: | 197.13 |
| InChI: | InChI=1/C5H12NO5P/c6-4(5(7)8)2-1-3-12(9,10)11/h4H,1-3,6H2,(H,7,8)(H2,9,10,11)/p-2/t4-/m1/s1 |
| Molecular Structure: |  |
| Properties | |
| Flash Point: | 245.4°C |
| Boiling Point: | 482.1°C at 760 mmHg |
| Density: | 1.529 g/cm3 |
| Appearance: | white fine crystalline powder |
| Specification: | white fine crystalline powder Safety Statements:26-36 26:In case of contact with eyes, rinse immediately with plenty of water and seek medical advice 36:Wear suitable protective clothing |
| Biological Activity: | Widely used competitive NMDA antagonist. More active form of AP5. Also agonist at quisqualate-sensitized AP6 site where it is less potent than the L-isomer (L-(+)-2-Amino-5-phosphonopentanoic acid ). Also available as part of the Mixed NMDA Receptor Tocriset™ . |
| Flash Point: | 245.4°C |
| Safety Data | |
 |
|
